Mortalin may block apoptosis and help cells to adapt to adverse microenvironments as mentioned above, or may chaperone the mutated proteins of cancer cells, such as mutated p53, which is observed in approximately 50% cancers [45] [46]. Here, HSPA9 is linked to cancer.